Literature DB >> 29095972

Placental Growth Factor Is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles.

Hannah R Bender1, Heidi A Trau1, Diane M Duffy1.   

Abstract

Placental growth factor (PGF) is member of the vascular endothelial growth factor (VEGF) family of angiogenesis regulators. VEGFA is an established regulator of ovulation and formation of the corpus luteum. To determine whether PGF also mediates aspects of ovulation and luteinization, macaques received gonadotropins to stimulate multiple follicular development. Ovarian biopsies and whole ovaries were collected before (0 hours) and up to 36 hours after human chorionic gonadotropin (hCG) administration to span the ovulatory interval. PGF and VEGFA were expressed by both granulosa cells and theca cells. In follicular fluid, PGF and VEGFA levels were lowest before hCG. PGF levels remained low until 36 hours after hCG administration, when PGF increased sevenfold to reach peak levels. Follicular fluid VEGFA increased threefold to reach peak levels at 12 hours after hCG, then dropped to intermediate levels. To explore the roles of PGF and VEGFA in ovulation, luteinization, and follicular angiogenesis in vivo, antibodies were injected into the follicular fluid of naturally developed monkey follicles; ovariectomy was performed 48 hours after hCG, with ovulation expected about 40 hours after hCG. Intrafollicular injection of control immunoglobulin G resulted in no retained oocytes, follicle rupture, and structural luteinization, including granulosa cell hypertrophy and capillary formation in the granulosa cell layer. PGF antibody injection resulted in oocyte retention, abnormal rupture, and incomplete luteinization, with limited and disorganized angiogenesis. Injection of a VEGFA antibody resulted in oocyte retention and very limited follicle rupture or structural luteinization. These studies demonstrate that PGF, in addition to VEGFA, is required for ovulation, luteinization, and follicular angiogenesis in primates.
Copyright © 2018 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29095972      PMCID: PMC5774250          DOI: 10.1210/en.2017-00739

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  50 in total

Review 1.  Intraovarian actions of anti-angiogenic agents disrupt periovulatory events during the menstrual cycle in monkeys.

Authors:  Fuhua Xu; Timothy M Hazzard; Amanda Evans; Stephen Charnock-Jones; Stephen Smith; Richard L Stouffer
Journal:  Contraception       Date:  2005-04       Impact factor: 3.375

2.  Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys.

Authors:  Timothy M Hazzard; Fuhua Xu; Richard L Stouffer
Journal:  Biol Reprod       Date:  2002-10       Impact factor: 4.285

3.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

4.  Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval.

Authors:  T M Hazzard; T A Molskness; C L Chaffin; R L Stouffer
Journal:  Mol Hum Reprod       Date:  1999-12       Impact factor: 4.025

Review 5.  Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway.

Authors:  Diane M Duffy
Journal:  Hum Reprod Update       Date:  2015-05-29       Impact factor: 15.610

6.  Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor.

Authors:  H M Fraser; S E Dickson; S F Lunn; C Wulff; K D Morris; V A Carroll; R Bicknell
Journal:  Endocrinology       Date:  2000-03       Impact factor: 4.736

7.  Vascular endothelial growth factors C and D may promote angiogenesis in the primate ovulatory follicle.

Authors:  Soon Ok Kim; Heidi A Trau; Diane M Duffy
Journal:  Biol Reprod       Date:  2017-02-01       Impact factor: 4.285

8.  Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.

Authors:  Guy Gutman; Vivian Barak; Sharon Maslovitz; Ami Amit; Joseph B Lessing; Eli Geva
Journal:  Fertil Steril       Date:  2008-03-17       Impact factor: 7.329

9.  The expression of angiogenic growth factors and their receptors in ovarian follicles throughout the estrous cycle in the ewe.

Authors:  M W H Chowdhury; R J Scaramuzzi; C P D Wheeler-Jones; M Khalid
Journal:  Theriogenology       Date:  2009-12-29       Impact factor: 2.740

Review 10.  Regulation of the ovarian follicular vasculature.

Authors:  Hamish M Fraser
Journal:  Reprod Biol Endocrinol       Date:  2006-04-12       Impact factor: 5.211

View more
  11 in total

Review 1.  Copper promotion of myocardial regeneration.

Authors:  Ying Xiao; Tao Wang; Xin Song; Dan Yang; Qing Chu; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2020-03-08

Review 2.  Ovulation: Parallels With Inflammatory Processes.

Authors:  Diane M Duffy; CheMyong Ko; Misung Jo; Mats Brannstrom; Thomas E Curry
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  Follicular fluid PlGF and IVF/ICSI outcomes among PCOS and normo-ovulatory women using different controlled hyperstimulation protocols: A prospective case-control study.

Authors:  Sally Kadoura; Marwan Alhalabi; Abdul Hakim Nattouf
Journal:  Ann Med Surg (Lond)       Date:  2022-06-25

4.  Neurotensin: A novel mediator of ovulation?

Authors:  Genevieve E Campbell; Hannah R Bender; Grace A Parker; Thomas E Curry; Diane M Duffy
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.191

Review 5.  Newly Identified Regulators of Ovarian Folliculogenesis and Ovulation.

Authors:  Eran Gershon; Nava Dekel
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

6.  Ovulation and ovarian wound healing are impaired with advanced reproductive age.

Authors:  Jamie N Mara; Luhan T Zhou; Megan Larmore; Brian Johnson; Rebecca Ayiku; Farners Amargant; Michele T Pritchard; Francesca E Duncan
Journal:  Aging (Albany NY)       Date:  2020-05-14       Impact factor: 5.682

7.  Effects of Melatonin on the Transcriptome of Human Granulosa Cells, Fertilization and Blastocyst Formation.

Authors:  Isao Tamura; Hiroshi Tamura; Mai Kawamoto-Jozaki; Yuichiro Shirafuta; Taishi Fujimura; Yumiko Doi-Tanaka; Yumiko Mihara; Toshiaki Taketani; Norihiro Sugino
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

8.  Neurotensin: a neuropeptide induced by hCG in the human and rat ovary during the periovulatory period†.

Authors:  Linah Al-Alem; Muraly Puttabyatappa; Ketan Shrestha; Yohan Choi; Kathy Rosewell; Mats Brännström; James Akin; Misung Jo; Diane M Duffy; Thomas E Curry
Journal:  Biol Reprod       Date:  2021-06-04       Impact factor: 4.285

9.  Thrombospondin 1 (THBS1) Promotes Follicular Angiogenesis, Luteinization, and Ovulation in Primates.

Authors:  Hannah R Bender; Genevieve E Campbell; Priyanka Aytoda; Allison H Mathiesen; Diane M Duffy
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-07       Impact factor: 5.555

10.  Identification of potential molecular targets associated with proliferative diabetic retinopathy.

Authors:  Dewang Shao; Shouzhi He; Zi Ye; Xiaoquan Zhu; Wei Sun; Wei Fu; Tianju Ma; Zhaohui Li
Journal:  BMC Ophthalmol       Date:  2020-04-14       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.